Cleveland Clinic’s Department of Nephrology and Hypertension, within the Glickman Urological and Kidney Institute, receives prestigious designation from the American Heart Association.
The veteran cardiologist reflects on the meeting’s biggest developments: the new cholesterol guideline, the VITAL trial of vitamin D, the REDUCE-IT controversy and a strikingly potent therapy for lowering Lp(a).
Understanding of atrial fibrillation (AF) risk factors and complications is based largely on studies that haven’t assessed AF burden. Our expert explains why that needs to change.
Interest in right-sided heart failure is on the upswing, but no formal statement has considered all major topics relevant to this syndrome. A new document from the AHA changes that.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A Cleveland Clinic study presented at the 2018 International Stroke Conference suggests these units may help bypass interhospital transfers for patients requiring thrombectomy.
The answer is yes, according to a new national database analysis, but the differences are limited and fairly focused on promptness of reperfusion therapy.
Cleveland Clinic ACNO participates in a collaborative study to ascertain the association between initial pharmacological therapy and mortality in heart failure patients with reduced ejection fraction.
Instead of one in three U.S. adults having hypertension, nearly one in two will now be classified as having hypertension. Accurate measurements in and out of the office are key. Lifestyle changes are getting major emphasis.
The physician-scientist draws the American Heart Association’s highest scientific honor for decades of pioneering research in multiple areas.
This video gives a glimpse of how a distance health approach designed to overcome alarm fatigue represents an exciting new paradigm in cardiac telemetry monitoring.